A Phase II, single-arm clinical trial of administration of cisplatin and 5-fluorouracil with afatinib as first-line therapy in patients with inoperable gastric or gastroesophageal junction cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 11 Oct 2017
At a glance
- Drugs Afatinib (Primary) ; Cisplatin (Primary) ; Fluorouracil (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms A-GAPP
- 31 Jul 2017 Planned End Date changed from 1 Dec 2017 to 1 Jun 2018.
- 31 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.
- 10 Jun 2017 Biomarkers information updated